| ABTS | 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) |
| ACSL4 | Acyl-CoA synthetase long chain family member 4 |
| ACC | Acetyl-CoA carboxylase |
| AKT/mTOR | Protein kinase B/mammalian target of rapamycin |
| AMPK | AMP-activated protein kinase |
| ARE | Antioxidant response element |
| BAX | BCL-2-associated X protein |
| BC cells | Bladder cancer cells |
| BCL-2 | B-cell lymphoma 2 |
| CAT | Catalase |
| CDK1 | Cyclin-dependent kinase 1 |
| CDK2 | Cyclin-dependent kinase 2 |
| CDK4/6 | Cyclin-dependent kinases 4 and 6 |
| CENP-A | Centromere protein A |
| ChREBP | Carbohydrate-responsive element-binding protein |
| CiC | Citrate carrier |
| CPT-1 | Carnitine palmitoyltransferase-1 |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl |
| E2F | E2F transcription factor |
| GAP | GTPase-activating protein |
| GEF | Guanine nucleotide exchange factor |
| GLP-1 | Glucagon-like peptide-1 |
| GLUT1 | Glucose transporter type 1 |
| GLUT4 | Glucose transporter type 4 |
| GLUT5 | Glucose transporter type 5 |
| GPX4 | Glutathione peroxidase 4 |
| GSH | Reduced glutathione |
| GDP | Guanosine diphosphate |
| GTP | Guanosine triphosphate |
| HCCLM3 | Human hepatocellular carcinoma cell line |
| HK1 | Hexokinase 1 |
| HNC cells | Head and neck cancer cells |
| IC50 | Half maximal inhibitory concentration |
| IFN-γ | Interferon gamma |
| IKKα/β/γ | Inhibitor of kappa B kinase subunits alpha, beta, gamma |
| IκB | Inhibitor of kappa B |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| IL-10 | Interleukin-10 |
| IRS-1 | Insulin receptor substrate 1 |
| KRAS | Kirsten rat sarcoma viral oncogene homolog |
| LDHA | Lactate dehydrogenase A |
| LRR | Leucine-rich repeat |
| MAPK | Mitogen-activated protein kinase |
| mTOR | Mammalian target of rapamycin |
| mTORC1 | Mechanistic target of rapamycin complex 1 |
| NACHT | NAIP, CIITA, HET-E, and TP1 domain |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | NOD-like receptor family pyrin domain containing 3 |
| Nrf2 | Nuclear factor erythroid 2–related factor 2 |
| OSCC | Oral squamous cell carcinoma |
| PAX3 | Paired box 3 |
| PARP-1 | Poly ADP-ribose polymerase-1 |
| PCNA | Proliferating cell nuclear antigen |
| PFKP | Phosphofructokinase |
| PI3K | Phosphoinositide 3-kinase |
| PPAR-α | Peroxisome proliferator-activated receptor alpha |
| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| PYD | Pyrin domain |
| RB | Retinoblastoma protein |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| SIRT1 | Sirtuin 1 |
| SOD | Superoxide dismutase |
| SREBP1 | Sterol regulatory element binding protein 1 |
| STAT1 | Signal transducer and activator of transcription 1 |
| STAT3 | Signal transducer and activator of transcription 3 |
| sMaf | Small musculoaponeurotic fibrosarcoma protein |
| TAB1/2/3 | TAK1-binding proteins 1, 2, and 3 |
| TAK1 | Transforming growth factor-β activated kinase 1 |
| TFC | Total flavonoid content |
| TLR | Toll-like receptor |
| TNF-α | Tumor necrosis factor alpha |
| TPC | Total phenolic content |
| TTC | Total tannin content |
| Treg | Regulatory T cells |
| Th1 | T helper 1 cells |
| Th17 | T helper 17 cells |
| UAE | Ultrasound-assisted extraction |